Comparison of resistance algorithms to determine prevalence of transmitted drug resistance

被引：0
|
作者：
Liu, L.
May, S.
Richman, D.
Pond, S. Kosakovsky
Frost, S.
Little, S.
Smith, D.
机构：
[1] Univ Calif San Diego, San Diego, CA USA
[2] Vet Adm San Diego Hlth Syst, San Diego, CA USA
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [21] Community HIV-1 drug resistance is associated with transmitted drug resistance
    Tilghman, M. W.
    Perez-Santiago, J.
    Osorio, G.
    Little, S. J.
    Richman, D. D.
    Mathews, W. C.
    Haubrich, R. H.
    Smith, D. M.
    HIV MEDICINE, 2014, 15 (06) : 339 - 346
  • [22] Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil
    Larissa Danielle Bahls
    Pedro Henrique Canezin
    Edna Maria Vissoci Reiche
    José Carlos Couto Fernandez
    José Ricardo Colleti Dias
    Vera Alice Fernandes Meneguetti
    Luis Toshio Ueda
    Dennis Armando Bertolini
    AIDS Research and Therapy, 16
  • [23] Prevalence and Transmission Dynamics of HIV-1 Transmitted Drug Resistance in a Southeastern Cohort
    Levintow, Sara N.
    Okeke, Nwora Lance
    Hue, Stephane
    Mkumba, Laura
    Virkud, Arti
    Napravnik, Sonia
    Sebastian, Joseph
    Miller, William C.
    Eron, Joseph J.
    Dennis, Ann M.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (08):
  • [24] PREVALENCE OF TRANSMITTED HIV DRUG RESISTANCE SINCE THE AVAILABILITY OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
    Russell, Jessica S.
    Chibo, Doris
    Kaye, Matthew B.
    Gooey, Megan L.
    Carolan, Louise A.
    Papadakis, Anastasia
    Nicholls, Jodie A.
    Birch, Chris J.
    COMMUNICABLE DISEASES INTELLIGENCE, 2009, 33 (02) : 216 - 220
  • [25] Prevalence and treatment implications of transmitted drug resistance among subjects with primary HIV infection
    Little, S. J.
    Osorio, G.
    Liu, L.
    Young, J. A.
    May, S.
    De Gruttola, V.
    Hecht, F. M.
    Markowitz, M.
    Daar, E. S.
    Routy, J. P.
    Collier, A. C.
    Margolick, J. B.
    Connick, E.
    Richman, D. D.
    ANTIVIRAL THERAPY, 2011, 16 : A76 - A76
  • [26] Prevalence of HIV Type 1 Transmitted Drug Resistance in Slovenia: 2005-2010
    Lunar, Maja M.
    Lepej, Snjezana Zidovec
    Abecasis, Ana B.
    Tomazic, Janez
    Vidmar, Ludvik
    Karner, Primoz
    Vovko, Tomaz D.
    Pecavar, Blaz
    Maver, Polona J.
    Seme, Katja
    Poljak, Mario
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (02) : 343 - 349
  • [27] Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil
    Bahls, Larissa Danielle
    Canezin, Pedro Henrique
    Vissoci Reiche, Edna Maria
    Couto Fernandez, Jose Carlos
    Colleti Dias, Jose Ricardo
    Fernandes Meneguetti, Vera Alice
    Ueda, Luis Toshio
    Bertolini, Dennis Armando
    AIDS RESEARCH AND THERAPY, 2019, 16 (1)
  • [28] High transmitted drug resistance in Brazil: unprecedented levels of INSTI resistance
    Caldeira, D. B.
    Vergara, T. R. C.
    Santos, E. L. B. d.
    Lopes, C. A. F.
    Alves, C. R. B.
    Caseiro, M. M.
    Treistman, M. S.
    Sousa, M. D. G.
    Fernandes, J. C.
    Sprinz, E.
    Galinskas, J.
    Mota, M. T. d. O.
    Schechter, M.
    Janini, L. M. R.
    Sobhie Diaz, R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 78 - 79
  • [29] HIV TRANSMITTED DRUG RESISTANCE IN LIMA, PERU
    Trebelcock, W.
    Lama, J.
    Duerr, A.
    Sanchez, H.
    Cabello, R.
    Reisner, S.
    Mayer, K.
    Ignacio, R. Bender
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (01) : 84 - 84
  • [30] HIV treatment decisions and transmitted drug resistance
    Little, SJ
    Smith, DM
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (02) : 233 - 235
12345